2nd Novel Immunotherapeutics Summit
Summit - San Diego, CA, United States
The 2nd Novel Immunotherapeutics Summit taking place on Jan 30 – Feb 1, 2013 in San Diego, brings together experts from academia and industry to discuss cutting edge research, immuno-strategies and novel therapeutics against various diseases. Topics such as cytokines, inflammation, cancer immunotherapy, immunomonitoring, biomarkers, immunosuppression, immunogenicity, immunotoxicity, allergy and asthma will be discussed at the summit.
The summit includes the following 4 concurrent tracks as well as an optional pre-summit workshop held on Jan 30, 2013.
2nd Novel Immunotherapeutics Summit:
Workshop: Immune Responses in Tumor Microenvironment
Track: 5th Immunotherapeutics & Immunomonitoring
Track: 11th Cytokines & Inflammation
Track: 2nd Allergy & Respiratory Drug Discovery
Track: Immunogenicity & Immunotoxicity
Network with representatives from prestigious organizations and discuss the latest research from top leaders in the pharmaceutical and biotech industries including Abbott, Bristol-Myer-Squibbs, Johnson & Johnson, Janssen Pharmaceuticals, Sanofi-Aventis, Eli Lilly, Merck, Pfizer, Amgen, Novo Nordisk, Dendreon, MedImmune, Athersys, Centocor, Elan, Biogen Idec, NIH, FDA, Genzyme, Harvard Medical School, Stanford University, MD Anderson Cancer Center, UC San Francisco, and many more!
(Courtesy of Westin Gaslamp Quarter, via commons.wikimedia.org)
2nd Novel Immunotherapeutics Summit
Wed, Jan 30, 2013 - Fri, Feb 01, 2013
The Westin Gaslamp Quarter San Diego
910 Broadway Circle, San Diego, CA 92101, United States
If you'd like to ask a question or post a comment about this talk please do so below.
This seminar posting is brought to you by Biotechnology Calendar, Inc. providing access to research information and research tools for nearly 20 years. Visit our Science Market Update Blog for current science funding and market information or see our schedule of upcoming science research laboratory product shows.
